Analyst Coverage
Analyst Coverage
The following research analysts cover Destiny Pharma.
| Mark Brewer, finnCap | +44(0)20 7220 0500 |
| Andy Smith, Equity Development | +44(0)20 7065 2690 |
Please click on links below to access coverage published:
 |
finnCap |
 |
Equity Development 17 September 2020 – Destiny Pharma – Interims – on track for Q1 2021 Phase 2b readout |